Bloodstream infections associated with parenteral nutrition preparation methods in the United States: A retrospective, large database analysis

Journal of Parenteral and Enteral Nutrition

Volumn 36, Issue 2, 2012, Pages 169-176

  Turpin, Robin S ^a,b   Canada, Todd ^c   Rosenthal, Victor ^d   Nitzki George, Diane ^e   Liu, Frank Xiaoqing ^a   Mercaldi, Catherine J ^f   Pontes Arruda, Alessandro ^g  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d International Nosocomial Infection Control Consortium   (Argentina)

^e NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^f UNITED BIOSOURCE CORPORATION   (United States)

^g Fernandes Tavora Hospital   (Brazil)

Author keywords

bloodstream; compounding; infection; multichamber bag; parenteral nutrition

Indexed keywords

ADULT; AGED; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOOD PROCESSING; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PARENTERAL NUTRITION; PHARMACY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; COMMERCE; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PARENTERAL NUTRITION SOLUTIONS; PHARMACEUTICAL SERVICES; PHARMACY SERVICE, HOSPITAL; SEPSIS; UNITED STATES;

EID: 84863250295     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607111414714     Document Type: Article

References (49)

1. Keith JN. Bedside nutrition assessment past, present and future: A review of the Subjective Global Assessment. Nutr Clin Pract. 2008 ; 23: 410-416
2. Heyland DK, McClave SA Principles of Critical Care. 3 rd ed. Columbus, OH: McGraw-Hill; 2005. Hall JB Schmidt GA Wood LDH, ed. Columbus, OH: McGraw-Hill ; 2005 :
3. European Public Health Alliance. The cost of malnutrition in the UK. http://www.epha.org/a/2080. Accessed on May 28, 2010.
4. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002 ; 26: 1SA - 138SA
5. Understanding Normal and Clinical Nutrition. 7 th ed. Belmont, CA: Thomson Wadsworth; 2006. Rolfes SR Pinna K Whitney E, ed. Belmont, CA: Thomson Wadsworth ; 2006 :
6. Forchielli ML, Miller SJ The A.S.P.E.N. Nutrition Support Practice Manual. 2 nd ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition; 2005:38-53. Merritt R, ed. Silver Spring, MD: American Society for Parenteral and Enteral Nutrition ; 2005: 38-53.
7. Braunschweig CL, Levy P, Sheean PM, Wang X. Enteral compared with parenteral nutrition: A meta-analysis. Am J Clin Nutr. 2001 ; 74: 534-542 (Pubitemid 32880266)
8. McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.). JPEN J Parenter Enteral Nutr. 2009 ; 33 (3). 277-316
9. Reduction in central-line associated bloodstream infection among patients in intensive care units-Pennsylvania-April 2001-March 2005. MMWR Morb Mortal Wkly Rep. 2005 ; 54: 1013-1016
10. Klevens RM, Edwards JR, Richards CL, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007 ; 122: 160-166
11. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct cost. Infect Control Hosp Epidemiol. 2002 ; 23: 190-197 (Pubitemid 34297272)
12. Kilgore M, Brossette S. Cost of bloodstream infections. Am J Infect Control. 2008 ; 36: S172.e1-3
13. Dissanaike S, Shelton M, Warner K, O'Keefe GE. The risk of bloodstream infections is associated with increased parenteral caloric intake in patients receiving parenteral nutrition. Crit Care. 2007 ; 11: R114
14. Opilla M. Epidemiology of bloodstream infection associated with parenteral nutrition. Am J Infect Control. 2008 ; 36: S173.e5-8
15. Beghetto MG, Victorino J, Teixeira L, Azevedo MJ. Parenteral nutrition as a risk factor for central venous catheter-related infection. JPEN J Parenter Enteral Nutr. 2005 ; 29: 367-373 (Pubitemid 44296705)
16. Holton D, Paton S, Conly J, Embree J, Taylor G, Thompson W. Central venous catheter-associated bloodstream infections occurring in Canadian intensive care units: A six-month cohort study. Can J Infect Dis Med Microbiol. 2006 ; 17: 169-176 (Pubitemid 44197394)
17. Kochevar M, Guenter P, Holcombe B, Malone A, Mirtallo J. A.S.P.E.N. Board of Directors and Task Force on Parenteral Nutrition Standardization. A.S.P.E.N. statement on parenteral nutrition standardization. JPEN J Parenter Enteral Nutr. 2007 ; 31: 441-448
18. Singer P, Berger MM, Van den Berghe G, et al. ESPEN guidelines on parenteral nutrition: intensive care. Clin Nutr. 2009 ; 28: 387-400
19. Ruano M, Recuenco I, Torrecilla A, et al. Standard formulas of parenteral nutrition: A study of their use in a general hospital. Nutr Hosp. 1993 ; 8: 242-248
20. Radzwell R. Compounding of IV admixtures for parenteral nutrition in German hospital pharmacist. Krankenhauspharmazie. 1997 ;: 230-232
21. Maisonneuve N, Raguso CA, Paoloni-Giacobino A, et al. Parenteral nutrition practices in hospital pharmacies in Switzerland, France, and Belgium. Nutrition. 2004 ; 20: 528-535 (Pubitemid 38692495)
22. Sanborn M. Core competencies in hospital pharmacy-intravenous admixtures. Hosp Pharm. 2006 ; 41: 377-380
23. USP 31/NF 26. Rockville, MD: The United States Pharmacopeial Convention ; 2008 :
24. Mirtallo J, Canada T, Johnson D, et al. Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr. 2004 ; 28: S39 - S70 (Pubitemid 39463819)
25. Scott EM, Gorman SP, Wyatt TD, Magill EA. Growth of microorganisms in total parenteral nutrition mixtures and related clinical observations. J Clin Hosp Pharm. 1985 ; 10 (1). 79-88 (Pubitemid 15103374)
26. Trissel LA, Gentempo JA, Anderson RW, Lajeunesse JD. Using a medium-fill simulation to evaluate the microbial contamination rate for USP medium-risk-level compounding. Am J Health Syst Pharm. 2005 ; 62: 285-288 (Pubitemid 40403543)
27. Trissel LA, Ogundele AB, Ingram DS, Saenz CA, Gentempo JA. Using medium-fill simulation to establish a benchmark microbiological contamination rate for low-risk-level compounding. Am J Health Syst Pharm. 2003 ; 60 (18). 1853-1855 (Pubitemid 39610566)
28. Kuwahara T, Kaneda S, Shimono K, Inoue Y. Growth of microorganisms in total parenteral nutrition solutions without lipid. Int J Med Sci. 2010 ; 7 (1). 43-47
29. Kuwahara T, Shimono K, Kaneda S, Tamura T, Ichihara M, Nakashima Y. Growth of microorganisms in total parenteral nutrition solutions containing lipid. Int J Med Sci. 2010 ; 7 (3). 101-109
30. Garland JS, Alex CP, Sevallius JM, et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol. 2008 ; 29 (3). 243-249 (Pubitemid 351269190)
31. Arslan U, Erayman I, Kirdar S, et al. Serratia marcescens sepsis outbreak in a neonatal intensive care unit. Pediatr Int. 2010 ; 52 (2). 208-212
32. DiazGranados CA, Martinez A, Deaza C, Valderrama S. An outbreak of Candida spp. bloodstream infection in a tertiary care center in Bogotá, Colombia. Braz J Infect Dis. 2008 ; 12 (5). 390-394
33. Mercaldi CJ, Reynolds MW, Turpin RS. Methods to identify and compare parenteral nutrition administered from hospital compounded and premixed multichamber bags in a retrospective hospital claims database. JPEN J Parenter Enteral Nutr. 2011 ;:
34. Yoshida J, Ishimaru T, Fujimoto M, Hirata N, Matsubara N, Koyanagi N. Risk factors for central venous catheter-related bloodstream infection: A 1073-patient study. J Infect Chemother. 2008 ; 14 (6). 399-403
35. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997 ; 127: 757-763 (Pubitemid 27446562)
36. U.S. Department of Health & Human Services. HHS Action Plan to Prevent Healthcare-Associated Infections. http://www.hhs.gov/ophs/initiatives/ hai/infection.html. Accessed July 7, 2010.
37. Guidelines for the prevention of intravascular catheter-related infections. MMWR Recomm Rep. 2002 ; 51: 1-29
38. Prevention of Hospital-Acquired Infections: A Practical Guide. 2 nd ed. Geneva, Switzerland: World Health Organization; 2002:30-37. Ducel G Fabry J Nicolle L, ed. Geneva, Switzerland: World Health Organization ; 2002: 30-37.
39. Donelli G. Vascular catheter-related infection and sepsis. Surg Infect (Larchmt). 2006 ; 7 (suppl 2). S25 - S27
40. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006 ; 355: 2725-2732 (Pubitemid 46021509)
41. Donolan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev. 2002 ; 15: 167-193 (Pubitemid 34303762)
42. Franzetti F, Borghi B, Raimondi F, Rosenthal VD. Impact on rates and time to first central vascular-associated bloodstream infection when switching from open to closed intravenous infusion containers in a hospital setting. Epidemiol Infect. 2009 ; 137: 1041-1048
43. Rangel-Frausto MS, Higuera F, Rosenthal VD, et al. Probability of developing a central vascular catheter-associated bloodstream infection when comparing open and closed infusion systems in Mexico. Presented at: Society for Healthcare Epidemiology of America 17th Annual Scientific Meeting ; Baltimore, MD ;..
44. Rosenthal V, Maki DG. Prospective study of the impact of open and closed infusion systems on rates of central venous catheter-associated bacteremia. Am J Infect Control. 2004 ; 32: 135-141 (Pubitemid 38620834)
45. Salomao R, Rosenthal VD, Blecher S, Maretti da Silva MA, Vilins M, da Silva EH. Probability of developing a central vascular catheter associated bloodstream infection when comparing open and closed infusion systems in Brazil. Presented at: 47th Annual Scientific Meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy ; Chicago, IL ;..
46. Salomao R, Blecher S, Rosenthal VD, Maretti da Silva MA, Vilins M, da Silva EH. Prospective study of the impact of switching from an open IV infusion system to a closed system on rates of central venous catheter-associated bloodstream infection in a Brazilian hospital. Presented at: Society for Healthcare Epidemiology of America 16th Annual Scientific Meeting ; Chicago, IL ;..
47. Tarricone R, Torbica A, Franzetti F, et al. Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers: the case of intensive care units in Italy. Cost Eff Resour Alloc. 2010 ; 8: 8
48. Weaver J, Willy M, Avigan M. Informatic tools and approaches in postmarketing pharmacovigilance used by FDA. AAPS J. 2008 ; 10: 35-41
49. Velentgas P, West W, Cannuscio CC, Watson DJ, Walker AM. Cardiovascular risk of selective cyclooxygenase-2 inhibitors and other non-aspirin non-steroidal anti-inflammatory medications. Pharmacoepidemiol Drug Saf. 2006 ; 15: 641-652 (Pubitemid 44404662)